A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma.

MLA

Larkin, James M. G., et al. “A Phase I/II Trial of Sorafenib and Infliximab in Advanced Renal Cell Carcinoma.” British Journal of Cancer, vol. 103, no. 8, Oct. 2010, pp. 1149–53. EBSCOhost, https://doi.org/10.1038/sj.bjc.6605889.

APA

Larkin, J. M. G., Ferguson, T. R., Pickering, L. M., Edmonds, K., James, M. G., Thomas, K., Banerji, U., Berns, B., de Boer, C., Gore, M. E., & Larkin, J. M. G. (2010). A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma. British Journal of Cancer, 103(8), 1149–1153. https://doi.org/10.1038/sj.bjc.6605889

Chicago

Larkin, James M. G., T. R. Ferguson, L. M. Pickering, K. Edmonds, M. G. James, K. Thomas, U. Banerji, et al. 2010. “A Phase I/II Trial of Sorafenib and Infliximab in Advanced Renal Cell Carcinoma.” British Journal of Cancer 103 (8): 1149–53. doi:10.1038/sj.bjc.6605889.